Position history for LOS ANGELES CAPITAL MANAGEMENT LLC's holdings in NEUROCRINE BIOSCIENCES INC
LOS ANGELES CAPITAL MANAGEMENT LLC holds 1.3M shares of NBIX (NEUROCRINE BIOSCIENCES INC), worth $178.2M as of 2025-Q4. The position was increased (++7.4% shares). NBIX represents 0.6% of LOS ANGELES CAPITAL MANAGEMENT LLC's portfolio.
Current Value
$178.2M
Current Shares
1.3M
Total Value Change
+$170.4M
Total Shares Change
+1.2M
Increased |
| 1.3M |
+7.4% |
| $178.2M |
| 0.6% |
| $140.95 |
46 |
| 2025-Q3 | Increased | 1.2M | +61.5% | $168.8M | 0.6% | $140.27 | 62 |
| 2025-Q2 | Increased | 744,650 | +195x | $93.6M | 0.4% | $125.42 | 58 |
| 2025-Q1 | Decreased | 3,808 | -99.3% | $421,165 | 0.0% | $113.16 | 0 |
| 2024-Q4 | Increased | 512,820 | +21.9% | $70M | 0.3% | $137.06 | 43 |
| 2024-Q3 | Increased | 420,748 | +639.6% | $48.5M | 0.2% | $115.06 | 56 |
| 2024-Q2 | Decreased | 56,885 | -76.8% | $7.8M | 0.0% | $137.67 | 0 |